Indefinite Delivery Contract SPE2DR25D9335

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of pharmaceutical products and related medical supplies to support the medical supply needs of Department of Defense (DoD) healthcare facilities worldwide.

The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract is a crucial component of the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which aims to establish multiple regional prime vendor contracts to ensure the resiliency and access to vital pharmaceuticals for DoD customers, the United States Coast Guard, and other government agencies during normal operations and contingency scenarios.